Formulation design and optimization of novel fast dissolving tablet of chlorpheniramine maleate by using lyophilization techniques

Aly, 2005, Superdisintegrants for solid dispersion to produce rapidly disintegrating tenoxicam tablet via camphor sublimation, Pharm. Technol., 68 Gaba, 2005, Nanostructured lipid carrier system for topical delivery of terbinafine hydrochloride, Bull. Faculty Pharm. Cairo Univ., 53, 147, 10.1016/j.bfopcu.2015.10.001 Chien, 1992 Vivek, 2012, Fast dissolving tablets: an overview, Int. J. Pharm. Sci. Rev. Res., 12, 35 Seager, 1998, Drug delivery product and the zydis fast dissolving dosage forms, J. Pharm. Pharmacol., 50, 375, 10.1111/j.2042-7158.1998.tb06876.x M.E. Aulton, The science of dosage form design, second ed., London, 2002. C.A. Gruetter, S.M. Lemke, D.K. Anestis, J.L. Szarek, M.A. Valentovic, Potentiation of 5-hydroxytryptamine-induced contraction in rat aorta by chlorpheniramine, citalopram and fluoxetine (1988) 146(1) 85–95. T. Mizumoto, Y. Masuda, A. Kajiyama, M. Yanagisawa, J.R. Nyshadham, Tablets quickly disintegrating in the oral cavity and process for producing the same, 2003, US Patent 6,589,554. P.P. Shah, R.C. Mashru, Development and evaluation of artemether taste masked rapid disintegrating tablets with improved dissolution using solid dispersion technique (2009) (9) 494–500. Fu, 2009, Therapeutic drug carrier systems orally fast disintegrating tablets: developments, technologies, taste-masking and clinical studies, Crit. Rev., 21, 433 Chien, 1992 Giri, 2010, Formulation aspects in the development of Orodispersible tablets: an Overview, IJPPS, 2, 38 C. Philippe, Coated granules based on angiotensin-converting enzyme inhibitor, 2001, US Patent 20040171669. Chang, 2000, Fast dissolving tablets, Pharm. Technol., 24, 52 Virely, 1990, Fast dissolving dosage form, Manufchem, 36 Prakash, 2011, Fast disintegrating tablets: opportunity in drug delivery system, J. Adv. Pharm. Technol. Res., 2, 223, 10.4103/2231-4040.90877 Lakshmi, 2011, Development and characterization of melt in mouth tablets of atenolol by sublimation technique, Int. J. Pharm. Res. Dev., 3, 27 Kalia, 2009, Formulation and evaluation of mouth dissolving tablets of oxcarbazepine, Int. J. Pharm. Sci., 1, 12 Danjo, 1994, Influence of the molecular weight of binding agents on the physical properties of granules and tablets, Chem. Pharm. Bull., 42, 2121, 10.1248/cpb.42.2121 Devi, 2010, Formulation and evaluation of oral disintegrating tablets of montelukast sodium, effect of functionality of superdisintegrants, J. Pharm. Res., 3, 803 Gandhi, 2011, A review: taste masking in pharmaceuticals, Int. J. Pharm. Res. Dev., 3, 19 Rajnibala, 2009, Development of non-bitter zolpidem tartrate mouth dissolving tablet, J. Pharm. Res., 2, 1530 Mukesh, 2009, Review on: fast dissolving tablet, J. Pharm. Res., 2, 5 B.S. Kaith, R. Sharma, S. Kalia, M.S. Bhatti, Response surface methodology and optimized synthesis of guar gum-based hydrogels with enhanced swelling capacity, RSC Adv 4:40339–40344. doi: 10.1039/C4RA05300A. Steinberg, 2014 Kharb, 2014, Formulation, evaluation and 3(2) full factorial design-based optimization of ondansetron hydrochloride incorporated taste masked microspheres, Pharm. Dev. Technol., 19, 839, 10.3109/10837450.2013.836220 Wilson, 1987, The behavior of a fast dissolving dosage form (Expidet) followed by g-scintigraphy, Int. J. Pharm., 40, 119, 10.1016/0378-5173(87)90056-1 Bi, 1996, Preparation and evaluation of a compressed tablet rapidly disintegrating in the oral cavity, Chem. Pharm. Bull., 44, 2121, 10.1248/cpb.44.2121 Nogami, 1969, Disintegration of the aspirin tablets containing potato starch and microcrystalline cellulose in various concentrations, Chem. Pharm. Bull., 17, 1450, 10.1248/cpb.17.1450 Kornblum, 1973, A new tablet disintegrating agent: cross-linked polyvinylpyrrolidone, J. Pharm. Sci., 62, 43, 10.1002/jps.2600620107 Shah, 2001, Evaluation of the functional equivalence of crospovidone NF from different sources. II. Standard performance test, Pharm. Dev. Technol., 6, 419, 10.1081/PDT-100002250 Soh, 2013, Characterization, optimisation and process robustness of a co-processed mannitol for the development of orally disintegrating tablets, Pharm. Dev. Technol., 18, 172, 10.3109/10837450.2012.685658 Thompson, 1981, Influence of substrate configuration on chlorpheniramine N-demethylation by hepatic microsomes from rats, rabbits, and mice, Drug Metab. Dispos., 9, 5 Velissaratou, 1989, In vitro release of chlorpheniramine maleate from oinment bases, Int. J. Pharm., 52, 83, 10.1016/0378-5173(89)90092-6 Babar, 1991, In vitro release studies of chlorpheniramine maleate from topical bases using cellulose membrane and hairless mouse skin, Drug Dev. Ind. Pharm., 17, 1027, 10.3109/03639049109043842 Nagar, 2011, Orally disintegrating tablets: formulation, preparation techniques and evaluation, J. Appl. Pharm. Sci., 01, 35 Gupta, 2009, Development of modified dosage form for enhancement of dissolution rate through amalgamation of solid dispersion and cube sugar or sintering technology using famotidine as a model drug, PDA J. Pharm. Sci. Technol., 63, 58 Ahmed, 2006, Formulation of a fast-dissolving ketoprofen tablet using freeze-drying in blisters technique, Drug Dev. Ind. Pharm., 32, 437, 10.1080/03639040500528913 Obaidat, 2011, Development and evaluation of fast-dissolving tablets of meloxicam-β-cyclodextrin complex prepared by direct compression, Acta Pharm., 61, 83, 10.2478/v10007-011-0005-7 Sarfraz, 2015, Formulation and evaluation of mouth disintegrating tablets of atenolol and atorvastatin, Indian J. Pharm. Sci., 77, 83, 10.4103/0250-474X.151602 Chien, 1981, Drug-disintegrant interactions: binding of oxymorphone derivatives, J. Pharm. Sci., 70, 709, 10.1002/jps.2600700641 Hollenbeck, 1983, Estimation of the extent of drug-excipient interactions involving croscarmellose sodium, J. Pharm. Sci., 72, 3250 Douroumis, 2011, Development and evaluation of cetirizine HCl taste-masked oral disintegrating tablets, AAPS PharmSciTech, 12, 141, 10.1208/s12249-010-9569-7 Martino, 2005, Evaluation of different fast melting disintegrants by means of a central composite design, Drug Dev. Ind. Pharm., 31, 109, 10.1081/DDC-44233 Shah, 2001, Evaluation of the functional equivalence of crospovidone NF from different sources. I. Physical characterization, Pharm. Dev. Technol., 6, 39, 10.1081/PDT-100000012 A. Modi and P. Tayade. Enhancement of dissolution profile by solid dispersion (kneading) technique. AAPS PharmSciTech 2006 Article 68. doi: 10.1208/pt070368. Ahmed, 2006, Formulation of fast dissolving ketoprofen tablet using freeze drying in blisters technique, Drug Dev. Ind. Pharm., 32, 437, 10.1080/03639040500528913 Gopal, 2010, Enhanced dissolution and bioavailability of Gliclazide using solid dispersion techniques, Int. J. Drug Dev., 2, 49, 10.5138/ijdd.2010.0975.0215.02011